ReShape Lifesciences

ReShape Lifesciences is a company located in San Clemente, United States. Available evidence confirms only its identity as a company and its location; no further details about its history, products, or operations are supported by the supplied sources.

• 2021.03.10

  Reported2021.03.10

  ReShape Lifesciences reports 2020 financial results[2]ReShape Lifesciences公布2020年财务业绩finanznachrichten.de

  ReShape Lifesciences reported its fourth-quarter and full-year 2020 financial and operational results, including full-year revenue of $11.3 million and a non-GAAP adjusted EBITDA loss of $9.1 million.

• 2019.11.05

  Reported2019.11.05

  ReShape Lifesciences partners with Sequence Health to market LAP-BAND[3]ReShape Lifesciences与Sequence Health合作推广LAP-BANDfinanznachrichten.de

  ReShape Lifesciences announced that it signed a marketing agreement with Sequence Health to promote LAP-BAND procedures in the United States. Sequence Health will run a targeted direct-to-patient digital marketing campaign.

• 2019.10.30

  Reported2019.10.30

  ReShape Lifesciences appoints Thomas Stankovich CFO[4]ReShape Lifesciences任命Thomas Stankovich为首席财务官finanznachrichten.de

  ReShape Lifesciences appointed Thomas Stankovich as chief financial officer, effective immediately.

Read more

1. 1ReShape Lifesciences (United States)wikidata.org
2. 2ReShape Lifesciences公布2020年财务业绩finanznachrichten.de
3. 3ReShape Lifesciences与Sequence Health合作推广LAP-BANDfinanznachrichten.de
4. 4ReShape Lifesciences任命Thomas Stankovich为首席财务官finanznachrichten.de